CGS-27913

N/A

Report date: 2023/05/24 13:30:24

Base Information

Drug NameCGS-27913
Drug Alias NameC5aRAM
ClassificationSmall molecules
Mechanisms of ActionC5a anaphylatoxin chemotactic receptor antagonists
TargetsC5a anaphylatoxin chemotactic receptor
Therapy Area/IndicationsReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsReperfusion Injury

Other Information

ATC CodeN/A
Related LinksN/A